James Harper

Jim is the co-founder and chief operating officer of Sonde Health. He has over 25 years of experience harnessing innovative technologies to provide real-world solutions to important biological measurement problems that he draws on to lead Sonde’s technology platform development to harness as a vital sign and meaningful predictor of health using devices they already own.

Prior to Sonde, Jim was at MIT Lincoln Laboratory for 15 years where he led the development of new biotechnology and bioengineering capabilities and teams for a range of national security applications and government agencies. The projects he led rapidly transformed novel biotechnologies from laboratory proofs-of-concept to prototypes and deployed systems that have impacted national security and law-enforcement capabilities in biodefense, human DNA identification and characterization, and human health and performance monitoring.

Jim received a BS in Biochemistry from Furman University, a PhD in Biochemistry from the MIT Chemistry department, and was a postdoctoral research fellow at Harvard Medical School in the Center for Neurologic Diseases.